22 septiembre 2015
One form of pancreatic cancer has a new enemy: a two-drug combination that inhibits tumors and kills cancer cells in mouse models. For the first time, researchers have shown that a certain protein becomes overabundant in pancreatic neuroendocrine tumors, allowing them to thrive. They also found that pairing a synthetic compound with an existing drug provides a more effective anticancer punch than a single drug.
http://www.sciencedaily.com/releases/2015/09/150922115637.htm
